Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Clinical trial NCT02648516 · UNKNOWN

Trial details

NCT number: NCT02648516
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Disorder of Immune Reconstitution

Start date: 2016-10-01
Primary completion: 2021-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.